Immuneering Corporation
USD5.05
+0.29 (+6.09%)
CEO
Benjamin J. Zeskind
IPO Date
2021-07-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.73
Prev. Close
$4.76
Day Low
$4.73
Day High
$5.14
52W Low
$2.90
52W High
$10.08
Market Cap
$0.18B
Volume
1.92M
| -1.1 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -59.0% | -52.1% | 0.05 | 11.35 | -3.9 |
| 31 Dec 2022 | FY | 50.1% | -15937.3% | -46.0% | -41.3% | 0.04 | 13.50 | -2.5 |
| 31 Dec 2021 | FY | 44.6% | -1612.3% | -21.5% | -20.1% | 0.03 | 27.04 | -12.7 |
| 31 Dec 2020 | FY | 44.6% | -737.2% | 75.8% | -44.3% | -0.03 | 16.73 | -13.9 |
| 31 Dec 2019 | FY | 36.3% | -401.6% | 118.1% | -54.7% | 0.00 | 27.83 | -30.8 |
| -6.3 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -6.6% | -6.2% | 0.02 | 24.00 | -4.6 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -49.9% | -36.0% | 0.14 | 3.70 | -2.1 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -36.0% | -29.7% | 0.10 | 7.48 | -0.9 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -43.6% | -34.2% | 0.10 | 5.28 | -0.9 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -25.3% | -21.3% | 0.07 | 7.99 | -1.3 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -21.2% | -18.3% | 0.07 | 9.39 | -0.6 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -18.2% | -16.3% | 0.06 | 14.38 | -1.4 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -16.7% | -14.7% | 0.05 | 11.35 | -3.6 |